HansBiomed Corporation (KOSDAQ: 042520)

HansBiomed Balance Sheet

Financials in millions KRW. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	8,024	6,132	7,524	7,051	13,841	10,404
Short-Term Investments	-	-	-	-	0	-0
Trading Asset Securities	-	916.26	6,030	13,217	9,022	15,559
Cash & Short-Term Investments	8,024	7,048	13,553	20,268	22,862	25,963
Cash Growth	0.80%	-48.00%	-33.13%	-11.35%	-11.94%	203.14%
Accounts Receivable	12,087	12,091	9,561	7,337	14,619	13,817
Other Receivables	765.23	779.81	459.59	2,388	782.8	983.27
Receivables	12,896	12,903	10,223	9,803	15,463	14,864
Inventory	27,039	27,798	26,936	18,673	17,740	15,209
Prepaid Expenses	-	733.24	579.89	433.2	1,077	998.54
Other Current Assets	2,533	1,911	3,079	1,935	1,553	1,751
Total Current Assets	50,492	50,393	54,371	51,113	58,696	58,785
Property, Plant & Equipment	44,130	44,234	46,934	46,591	47,247	44,535
Long-Term Investments	7,227	4,356	6,222	8,926	100	200
Goodwill	-	-	-	-	880.58	7,703
Other Intangible Assets	700.96	755.83	899.8	1,031	2,538	1,809
Long-Term Deferred Tax Assets	2,202	2,318	2,636	734.37	3,126	2,271
Long-Term Deferred Charges	-	-	-	89.19	178.38	328.68
Other Long-Term Assets	20,009	20,132	20,464	20,756	18,844	18,294
Total Assets	124,957	122,368	131,686	129,445	131,806	134,095
Accounts Payable	1,922	2,114	1,984	1,204	2,435	1,693
Accrued Expenses	1,086	947.38	841.76	743.93	769.41	209.93
Short-Term Debt	31,300	39,450	53,553	27,300	9,586	10,000
Current Portion of Long-Term Debt	-	-	-	9,000	-	-
Current Portion of Leases	1,152	942.13	1,010	740.52	562.18	-
Current Income Taxes Payable	-	109.47	320.37	-	1,483	1,751
Other Current Liabilities	10,450	21,691	16,734	22,002	13,256	10,523
Total Current Liabilities	45,909	65,253	74,443	60,991	28,092	24,177
Long-Term Debt	-	-	-	12,879	22,109	23,597
Long-Term Leases	1,275	749.26	1,347	1,658	589.35	-
Other Long-Term Liabilities	3,636	6,417	8,441	6,336	11,717	2,252
Total Liabilities	50,819	72,419	84,231	81,863	62,507	50,025
Common Stock	6,763	6,058	5,051	5,051	5,051	4,951
Additional Paid-In Capital	82,224	58,621	32,288	32,288	32,288	27,211
Retained Earnings	-8,740	-7,759	15,286	9,139	25,041	44,016
Treasury Stock	-5,833	-5,833	-5,055	-884.32	-884.32	-130.15
Comprehensive Income & Other	-568.86	-1,958	-1,937	-1,143	-1,160	-1,166
Total Common Equity	73,845	49,129	45,634	44,451	60,336	74,882
Minority Interest	292.77	819.76	1,821	3,130	8,963	9,188
Shareholders' Equity	74,138	49,949	47,455	47,581	69,299	84,070
Total Liabilities & Equity	124,957	122,368	131,686	129,445	131,806	134,095
Total Debt	33,727	41,141	55,910	51,577	32,847	33,597
Net Cash (Debt)	-25,702	-34,093	-42,356	-31,309	-9,984	-7,634
Net Cash Per Share	-2038.39	-3181.12	-3224.39	-3127.17	-1012.05	-776.67
Filing Date Shares Outstanding	12.99	11.58	9.64	10.01	10.01	9.86
Total Common Shares Outstanding	12.99	11.58	9.64	10.01	10.01	9.86
Working Capital	4,583	-14,860	-20,072	-9,878	30,604	34,609
Book Value Per Share	5686.06	4243.81	4732.03	4439.82	6026.47	7592.23
Tangible Book Value	73,144	48,373	44,734	43,420	56,918	65,369
Tangible Book Value Per Share	5632.09	4178.52	4638.72	4336.84	5685.03	6627.73
Land	12,459	12,542	12,525	12,525	13,308	13,858
Buildings	16,887	17,309	17,649	18,110	20,054	19,674
Machinery	8,123	8,158	8,920	7,919	6,739	3,667
Construction In Progress	1,356	1,262	1,043	1,603	2,021	6,630

Source: S&P Capital IQ. Standard template. Financial Sources.